Market Overview:
The global varicella zoster infection treatment drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of varicella zoster infections, rising demand for better and faster-acting drugs, and growing awareness about available treatments. Based on type, the global varicella zoster infection treatment drugs market is segmented into acyclovir, valacyclovir, famciclovir, and others. Acyclovir is currently the most popular drug for treating varicella zoster infections and is expected to maintain its leading position during the forecast period. However, valacyclovir is expected to grow at a higher CAGR due to its superior efficacy and safety profile as compared with other drugs in this category. Based on application, the global varicella zoster infection treatment drugs market can be segmented into hospital pharmacies, retail pharmacies, online pharmacies,. The hospital pharmacies segment dominates this market owing to increased use of these medications in hospitals for patients with compromised immune systems or those who are admitted specifically for treatment of a Varicella Zoster Infection (VZI).
Product Definition:
Varicella zoster virus (VZV) is the cause of chickenpox and shingles. The primary infection, chickenpox, is highly contagious and usually occurs in childhood. After a person recovers from chickenpox, the virus remains dormant in the nervous system. In some people, it reactivates years later to cause shingles.Shingles is a painful rash that usually occurs on one side of the body. Treatment for both chickenpox and shingles includes medications to relieve symptoms and shorten the course of illness."Varicella Zoster Infection Treatment Drugs" are prescription drugs used to treat varicella zoster virus (VZV) infections such as chickenpox and shingles. These drugs include acyclovir (Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir).
Acyclovir:
Acyclovir is a nucleic acid polymerase enzyme inhibitor. It works by decreasing the activity of DNA and RNA-based virus enzymes. Acyclovir was first discovered in the early 1980s and has been used as an antiviral agent for treating several diseases, including foot & mouth disease, influenza, hand-foot-mouth disease (HFMD), zoster (shingles), cytomegalovirus infection, HIV aids infection among others.
Valacyclovir:
Valacyclovir is an antiviral drug used for the treatment of chickenpox and shingles (herpes zoster). It is also used to prevent infection in people who are prone to chickenpox or those having recovered from chickenpox. Valacyclovir hydrochloride tablets are white crystalline powder derived from valine, threonine, and lysine. It has a molecular weight of 132.46 and pKw of 7.2-7.
Application Insights:
The chickenpox application segment led the global varicella zoster infection treatment drugs market in 2017. The hospital pharmacies segment is expected to witness lucrative growth over the forecast period due to increasing awareness about VZV-related diseases and rising incidences of chickenpox among children. Hospital-based pharmacists are involved in dispensing of antiviral drugs, which is anticipated to boost product demand globally during this period.
The availability of a wide range of products for treating chickenpox at retail pharmacies and online pharmacies also contributes toward revenue generation for this segment. Moreover, growing penetration of social media websites that provide information related to new medicines available in the market is likely to fuel product demand from 2018 to 2030 globally as patients seek medical advice from friends and relatives regarding their symptoms insteadof visiting doctors or hospitals frequently leading towards increased usage rates across all three applications worldwide during this period.
Regional Analysis:
North America accounted for the largest share of global revenue in 2017. The presence of a large number of manufacturers and suppliers, high healthcare expenditure, better reimbursement scenario and higher awareness levels are some factors contributing to its dominance. Moreover, the availability of novel drugs is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to increasing disposable income levels in emerging economies such as India & China and rising prevalence of infectious diseases such as varicella zoster infection (VZV). In addition, improving healthcare infrastructure will also support market growth during this period. Furthermore, an increase in government initiatives pertaining towards controlling VZV infections will further propel market development over the next eight years.
Growth Factors:
- Increasing incidence of varicella zoster infection (VZI) due to changing demographics and increasing awareness about the disease.
- Growing demand for better and more effective drugs for the treatment of VZI.
- Introduction of new drugs with better efficacy and safety profiles in the market.
- Rising number of clinical studies being conducted on VZI drugs to assess their safety and efficacy profiles.
Scope Of The Report
Report Attributes
Report Details
Report Title
Varicella Zoster Infection Treatment Drugs Market Research Report
By Type
Acyclovir, Valacyclovir, Famciclovir, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Roche, Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Varicella Zoster Infection Treatment Drugs Market Report Segments:
The global Varicella Zoster Infection Treatment Drugs market is segmented on the basis of:
Types
Acyclovir, Valacyclovir, Famciclovir, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Merck
- Pfizer
- Novartis
- Abbott
- GlaxoSmithKline
- Sanofi
- Eli Lilly
- Astrazeneca
- Johnson & Johnson
- Roche
Highlights of The Varicella Zoster Infection Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acyclovir
- Valacyclovir
- Famciclovir
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Varicella Zoster Infection Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Varicella zoster infection (VZV) is a highly contagious virus that can cause chickenpox. The most common treatment for VZV is the use of antiviral medications. These medications help to prevent or reduce the severity of symptoms, including fever, rash, and muscle aches. Some people may also need to take antibiotics if they develop pneumonia as a result of VZV infection.
Some of the key players operating in the varicella zoster infection treatment drugs market are Roche, Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Roche.
The varicella zoster infection treatment drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Varicella Zoster Infection Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Varicella Zoster Infection Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Varicella Zoster Infection Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Varicella Zoster Infection Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Varicella Zoster Infection Treatment Drugs Market Size & Forecast, 2018-2028
4.5.1 Varicella Zoster Infection Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Varicella Zoster Infection Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Varicella Zoster Infection Treatment Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
5.2.1 Acyclovir
5.2.2 Valacyclovir
5.2.3 Famciclovir
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Varicella Zoster Infection Treatment Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Varicella Zoster Infection Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Varicella Zoster Infection Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Varicella Zoster Infection Treatment Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
9.6.1 Acyclovir
9.6.2 Valacyclovir
9.6.3 Famciclovir
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Varicella Zoster Infection Treatment Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Varicella Zoster Infection Treatment Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
10.6.1 Acyclovir
10.6.2 Valacyclovir
10.6.3 Famciclovir
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Varicella Zoster Infection Treatment Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Varicella Zoster Infection Treatment Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
11.6.1 Acyclovir
11.6.2 Valacyclovir
11.6.3 Famciclovir
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Varicella Zoster Infection Treatment Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
12.6.1 Acyclovir
12.6.2 Valacyclovir
12.6.3 Famciclovir
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Varicella Zoster Infection Treatment Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Varicella Zoster Infection Treatment Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Varicella Zoster Infection Treatment Drugs Market Size Forecast by Type
13.6.1 Acyclovir
13.6.2 Valacyclovir
13.6.3 Famciclovir
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Varicella Zoster Infection Treatment Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Varicella Zoster Infection Treatment Drugs Market: Competitive Dashboard
14.2 Global Varicella Zoster Infection Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Merck
14.3.3 Pfizer
14.3.4 Novartis
14.3.5 Abbott
14.3.6 GlaxoSmithKline
14.3.7 Sanofi
14.3.8 Eli Lilly
14.3.9 Astrazeneca
14.3.10 Johnson & Johnson
14.3.11 Roche
